Bridgewater Associates’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Bridgewater Associates’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-151,560	Closed	-$524K	–	737
2023 Q1	$524K	Sell	151,560 -54,223	-26%	-$263K	﹤0.01%	642
2022 Q4	$860K	Sell	205,783 -7,623	-4%	-$28.9K	﹤0.01%	658
2022 Q3	$856K	Sell	213,406 -36,117	-14%	-$274K	﹤0.01%	721
2022 Q2	$2.82M	Sell	249,523 -62,475	-20%	-$749K	0.01%	609
2022 Q1	$5.07M	Buy	311,998 +126,384	+68%	+$3.24M	0.02%	468
2021 Q4	$8.8M	Buy	185,614 +39,630	+27%	+$2.38M	0.05%	209
2021 Q3	$10.6M	Buy	145,984 +112,730	+339%	+$8.15M	0.06%	198
2021 Q2	$2.79M	Buy	+33,254	New	+$2.19M	0.02%	434

Other funds holding NBP

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bridgewater Associates's NBP Position: Q2 2023 in Review

Bridgewater Associates sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q2 2023, closing a stake of 151,560 shares — an estimated $524K sold.

Bridgewater Associates first reported a position in NBP in Q2 2021 and held it in 8 quarters. The position peaked at $10.6M in Q3 2021. 48 funds tracked by Wall St. Rank hold NBP as of Q2 2023.

Bridgewater Associates reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q2 2023 after selling out during the quarter.
Bridgewater Associates sold 151,560 NovaBridge Biosciences American Depositary Shares shares in Q2 2023, an estimated $524K.
Bridgewater Associates first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2021 and held it in 8 quarters.
Bridgewater Associates's NovaBridge Biosciences American Depositary Shares position peaked at $10.6M in Q3 2021.
48 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2023.

Based on Bridgewater Associates's 13F filing for Q2 2023, filed 11 Aug 2023.